How have COCP and KTTA total returns compared?

Over the past 5 years, COCP delivered -37.50% and KTTA delivered -61.48% annualized total return. Past performance doesn't predict future results.

Cocrystal Pharma, Inc. (COCP) vs Pasithea Therapeutics Corp. (KTTA)

A side-by-side comparison of Cocrystal Pharma, Inc. and Pasithea Therapeutics Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

COCP

Cocrystal Pharma, Inc.

$15M

$1.11HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT

KTTA

Pasithea Therapeutics Corp.

$15M

$0.46HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT

Total return — COCP vs KTTA

growth of $100 · dividends reinvested · last 5y

COCP -91.5% (-38.9%/yr)KTTA -99.4% (-63.6%/yr)COCP compounded faster over this window

Log scale — wide-divergence pair

COCP KTTA

COCP vs KTTA: by the numbers

•COCP is the larger company ($15M vs $15M market cap).
•Both run net losses; KTTA's is the smaller (0.00% vs -3011.52% net margin).

Metrics side by side

Valuation

Metric	COCP	KTTA
P/S ratio	46.38	N/A
P/B ratio	14.66	0.31

Profitability

Metric	COCP	KTTA
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	-3011.52%	0.00%
ROE	-951.92%	-42.72%
ROIC	-497.29%	-48.04%

Growth (annualized)

Metric	COCP	KTTA
Revenue CAGR (5Y)	91.55%	N/A
Total return CAGR (5Y)	-37.50%	-61.48%

Frequently asked

How have COCP and KTTA total returns compared?: Over the past 5 years, COCP delivered -37.50% and KTTA delivered -61.48% annualized total return. Past performance doesn't predict future results.

Go deeper

Full COCP analysis Full KTTA analysis Interactive comparison tool

Dig into the metrics

Cocrystal Pharma ROE Pasithea Therapeutics ROE Cocrystal Pharma operating margin Pasithea Therapeutics operating margin Cocrystal Pharma revenue growth Pasithea Therapeutics revenue growth Cocrystal Pharma free cash flow Pasithea Therapeutics free cash flow

Cocrystal Pharma & Pasithea Therapeutics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.